Brokerages Anticipate Sientra, Inc. (NASDAQ:SIEN) to Announce -$0.23 Earnings Per Share

Equities analysts expect Sientra, Inc. (NASDAQ:SIEN) to post earnings per share of ($0.23) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Sientra’s earnings, with the highest EPS estimate coming in at ($0.21) and the lowest estimate coming in at ($0.24). Sientra posted earnings of ($0.38) per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 39.5%. The firm is expected to report its next quarterly earnings results on Monday, August 9th.

According to Zacks, analysts expect that Sientra will report full year earnings of ($1.65) per share for the current fiscal year, with EPS estimates ranging from ($1.66) to ($1.62). For the next year, analysts expect that the company will report earnings of ($0.69) per share, with EPS estimates ranging from ($0.78) to ($0.58). Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that follow Sientra.

Sientra (NASDAQ:SIEN) last announced its quarterly earnings results on Tuesday, May 11th. The medical instruments supplier reported ($1.01) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.28) by ($0.73). The company had revenue of $23.24 million during the quarter, compared to analyst estimates of $18.23 million. Sientra had a negative net margin of 149.62% and a negative return on equity of 901.29%.

A number of equities analysts have recently commented on the company. SVB Leerink raised their price objective on Sientra from $10.00 to $11.00 and gave the stock an “outperform” rating in a report on Wednesday, May 12th. Canaccord Genuity lifted their price target on shares of Sientra from $9.00 to $10.00 and gave the company a “buy” rating in a research report on Tuesday, May 18th. Finally, Zacks Investment Research lowered shares of Sientra from a “buy” rating to a “hold” rating in a research report on Saturday, May 15th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $9.88.

Sientra stock traded down $0.11 during midday trading on Thursday, reaching $7.25. The stock had a trading volume of 23,963 shares, compared to its average volume of 942,807. The firm has a 50-day moving average price of $7.05. Sientra has a twelve month low of $3.21 and a twelve month high of $8.93. The company has a debt-to-equity ratio of 3.50, a current ratio of 2.29 and a quick ratio of 1.56. The stock has a market capitalization of $417.03 million, a PE ratio of -3.24 and a beta of 2.13.

Several institutional investors and hedge funds have recently bought and sold shares of SIEN. American International Group Inc. boosted its stake in shares of Sientra by 11.9% in the first quarter. American International Group Inc. now owns 30,193 shares of the medical instruments supplier’s stock valued at $220,000 after purchasing an additional 3,214 shares during the period. Virtu Financial LLC lifted its holdings in Sientra by 258.3% in the 4th quarter. Virtu Financial LLC now owns 62,992 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 45,411 shares in the last quarter. OLD Mission Capital LLC acquired a new stake in shares of Sientra during the third quarter valued at about $219,000. ProShare Advisors LLC acquired a new stake in shares of Sientra during the fourth quarter valued at about $40,000. Finally, HighMark Wealth Management LLC acquired a new position in shares of Sientra in the first quarter worth about $43,000. Institutional investors own 80.37% of the company’s stock.

About Sientra

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Recommended Story: Why does a company issue an IPO?

Get a free copy of the Zacks research report on Sientra (SIEN)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with's FREE daily email newsletter.